#ICYMI @debaditya_roy@twitter.com's #ACR22 abstract highlights

https://twitter.com/debaditya_roy/status/1588216970708930560?s=20&t=0OmX0McGP8y7H6AgMqY3qQ

RT @debaditya_roy@twitter.com

#Myositis #Cancer #IIM
👥201 patients

💫#Sp4 in 12.5% of DM and 1% of PM
💫Sp4 M/c with anti-TIF1(55%) f/b, anti-MDA5 (36%),anti-Mi-2(18%)

✅Among Anti TIF 1Y 👇

🔥NONE of anti-SP4 Ab+ DM patients had cancer @ diagnosis

🔥60% without anti-SP4 had Cancer
#ACR22 #ACRambassador

🐦🔗: https://twitter.com/debaditya_roy/status/1588216970708930560